What does Apotheek Veldstraat do?

Apotheek Veldstraat is a pharmacy in Gent. Private Limited, started on 30 July 2013, 1 establishment.

What is the address of Apotheek Veldstraat?

The registered office of Apotheek Veldstraat is located at Veldstraat 66, 9000 Gent.

Is Apotheek Veldstraat still active?

Yes. According to the CBE (15 November 2026) Apotheek Veldstraat is active, legal situation “Normale toestand”, started on 30 July 2013.

Is Apotheek Veldstraat registered on Peppol?

Yes, Apotheek Veldstraat is registered on the Peppol network with ID 0208:0537205103.

What is the enterprise number of Apotheek Veldstraat?

The enterprise number of Apotheek Veldstraat is BE0537205103.

When was Apotheek Veldstraat founded?

Apotheek Veldstraat was founded on 30 July 2013.

Who are the directors of Apotheek Veldstraat?

According to the 2025 annual accounts, the directors of Apotheek Veldstraat are: Nice by Nys BV.

Is Apotheek Veldstraat a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 July 2013; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did Apotheek Veldstraat make in 2025?

Apotheek Veldstraat posted a profit after taxes of € 50,153 in financial year 2025.

What is the revenue of Apotheek Veldstraat?

As a small company, Apotheek Veldstraat is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 148,636.

How much does an employee at Apotheek Veldstraat earn?

The average wage cost per full-time employee at Apotheek Veldstraat was € 46,900 in 2025: staff costs of € 60,966 for 1.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Veldstraat have?

According to the 2025 annual accounts, Apotheek Veldstraat has 1.3 full-time equivalents (FTE).

Apotheek Veldstraat (Private Limited) - Gent

Dossier Apotheek Veldstraat, printed on 15 November 2026 from databakkes.be/en/0537205103/apotheek-veldstraat. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Veldstraat from Gent, company number BE0537205103, closed financial year 2025 with a result of € 50,153 after tax. For that financial year Apotheek Veldstraat recorded a gross margin of € 148,636 and equity of € 134,510. Compared with financial year 2024, the result moved from € 173,223 to € 50,153. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.

What it is worth Growing

€ 134,510

▲ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 50,153

▼ 71% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 31,718

▼ 57% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 33,648 paid out

67 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

1.3

▲ 0.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 60,966

▲ 90% vs 2024

€ 46,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,699

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 79,811

▲ 11% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 29,522

▼ 57% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 328,377 Gross margin 2022: € 328,377 First fiscal year in the series	€ 301,437 Gross margin 2023: € 301,437 ▼ 8% vs 2022 (€ 328,377) Unfavourable step	€ 251,593 Gross margin 2024: € 251,593 ▼ 17% vs 2023 (€ 301,437) Unfavourable step	€ 148,636 Gross margin 2025: € 148,636 ▼ 41% vs 2024 (€ 251,593) Unfavourable step	▼ 41%
Profit after taxes	€ 144,037 Profit after taxes 2022: € 144,037 First fiscal year in the series	€ 122,872 Profit after taxes 2023: € 122,872 ▼ 15% vs 2022 (€ 144,037) Unfavourable step	€ 173,223 Profit after taxes 2024: € 173,223 ▲ 41% vs 2023 (€ 122,872) Favourable step	€ 50,153 Profit after taxes 2025: € 50,153 ▼ 71% vs 2024 (€ 173,223) Unfavourable step	▼ 71%
Equity	€ 320,861 Equity 2022: € 320,861 First fiscal year in the series	€ 443,733 Equity 2023: € 443,733 ▲ 38% vs 2022 (€ 320,861) Favourable step	€ 118,005 Equity 2024: € 118,005 ▼ 73% vs 2023 (€ 443,733) Unfavourable step	€ 134,510 Equity 2025: € 134,510 ▲ 14% vs 2024 (€ 118,005) Favourable step	▲ 14%
Total debts	€ 232,135 Total debts 2022: € 232,135 First fiscal year in the series	€ 87,345 Total debts 2023: € 87,345 ▼ 62% vs 2022 (€ 232,135) Favourable step	€ 584,025 Total debts 2024: € 584,025 ▲ € 496,680 vs 2023 (€ 87,345) Unfavourable step	€ 230,538 Total debts 2025: € 230,538 ▼ 61% vs 2024 (€ 584,025) Favourable step	▼ 61%
Cash	€ 151,450 Cash 2022: € 151,450 First fiscal year in the series	€ 300,111 Cash 2023: € 300,111 ▲ 98% vs 2022 (€ 151,450) Favourable step	€ 73,231 Cash 2024: € 73,231 ▼ 76% vs 2023 (€ 300,111) Unfavourable step	€ 31,718 Cash 2025: € 31,718 ▼ 57% vs 2024 (€ 73,231) Unfavourable step	▼ 57%
Retained profit	€ 300,861 Retained profit 2022: € 300,861 First fiscal year in the series	€ 423,733 Retained profit 2023: € 423,733 ▲ 41% vs 2022 (€ 300,861) Favourable step	€ 98,005 Retained profit 2024: € 98,005 ▼ 77% vs 2023 (€ 423,733) Unfavourable step	€ 114,510 Retained profit 2025: € 114,510 ▲ 17% vs 2024 (€ 98,005) Favourable step	▲ 17%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 498,951 Dividend 2024: € 498,951 Unchanged (€ 0) Unchanged	€ 33,648 Dividend 2025: € 33,648 ▼ 93% vs 2024 (€ 498,951) Unchanged	▼ 93%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 1,341 Bank debt 2023: € 1,341 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 1,341) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 552,996 Balance sheet total 2022: € 552,996 First fiscal year in the series	€ 531,078 Balance sheet total 2023: € 531,078 ▼ 4% vs 2022 (€ 552,996) Unchanged	€ 702,030 Balance sheet total 2024: € 702,030 ▲ 32% vs 2023 (€ 531,078) Unchanged	€ 365,048 Balance sheet total 2025: € 365,048 ▼ 48% vs 2024 (€ 702,030) Unchanged	▼ 48%
Employees (FTE)	-	3.1 Employees (FTE) 2023: 3.1 First fiscal year in the series	1 Employees (FTE) 2024: 1 ▼ 2.1 vs 2023 (3.1) Unchanged	1.3 Employees (FTE) 2025: 1.3 ▲ 0.3 vs 2024 (1) Unchanged	▲ 0.3

By gross margin, Apotheek Veldstraat ranks 20th of 51 companies with main activity “Detailhandel in farmaceutische producten” in Gent that publish figures (fiscal year 2025).

Key figures of Apotheek Veldstraat, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about Apotheek Veldstraat the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to Apotheek Veldstraat?

What happened at Apotheek Veldstraat in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 24, 2026 New annual accounts for financial year 2025: profit of € 50,153 (▼ 71% vs 2024). filed late Source: NBB ↗
Aug 9, 2013 Incorporation, published in the Gazette. Source: Staatsblad ↗
Jul 30, 2013 New establishment in Gent. KBO